Monash IVF Group (ASX:MVF) ROCE %: 6.06% (As of Dec. 2025)


ASX:MVF Monash IVF Group Ltd ASX:MVF
78 GF Score
Price A$0.71
GF Value A$1.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Monash IVF Group ROCE %?

Monash IVF Group ASX:MVF 78 ROCE % is 6.06% as of Dec. 2025. GuruFocus rates ASX:MVF with a GF Score™ of 78/100 and a GF Value™ of A$1.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Monash IVF Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.06%.

Monash IVF Group  (ASX:MVF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Monash IVF Group ROCE % Related Terms

Monash IVF Group ROCE % Historical Data

* Premium members only.

The historical data trend for Monash IVF Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monash IVF Group ROCE % Chart

Monash IVF Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.84 8.10 8.52 -2.00 9.87

Monash IVF Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.30 -14.20 13.07 6.75 6.06
ASX:MVF
78GF Score
Monash IVF Group Ltd ASX:MVF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Monash IVF Group ROCE % Calculation

Monash IVF Group's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=40.903/( ( (516.648 - 118.821) + (492.607 - 61.414) )/ 2 )
=40.903/( (397.827+431.193)/ 2 )
=40.903/414.51
=9.87 %

Monash IVF Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=26.874/( ( (492.607 - 61.414) + (510.21 - 53.854) )/ 2 )
=26.874/( ( 431.193 + 456.356 )/ 2 )
=26.874/443.7745
=6.06 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.06% mean?
Monash IVF Group (ASX:MVF) has a ROCE % of 6.06% as of Dec. 2025.
Is Monash IVF Group's ROCE % too high?
Monash IVF Group's current ROCE % is 6.06%. Overall, Monash IVF Group has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's ROCE % compare to TMO and DHR?
Monash IVF Group's ROCE % of 6.06% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Monash IVF Group's current ROCE % is 6.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.39, compared to a current price of A$0.71 — trading 48.9% below its estimated fair value. The current ROCE % is 6.06%. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current ROCE % is 6.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monash IVF Group (ASX:MVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of A$0.71 is trading 48.9% below its estimated GF Value™ of A$1.39. GuruFocus considers Monash IVF Group to be Possible Value Trap.

Key valuation signals for ASX:MVF:

  • ROCE %: 6.06%
  • GF Value™: A$1.39 vs. price of A$0.71 (48.9% below fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score

Get the complete analysis for ASX:MVF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.71
Price
A$1.39
GF Value